Explore 3 Stock Ideas & Industry Insights Download Free Report
Eden Research, Britain’s only listed pure-play biopesticide developer, has just banked a run of fresh regulatory wins across Europe and North Africa. Yet the AIM tiddler’s shares have drifted lower, leaving investors to weigh a widening product pipeline against the reality of aBusinessthat still …
AstraZeneca shares gained0.87% on 17 August 2026, despite the pharmaceutical company announcing the discontinuation of a major late-stage lung-cancer trial.
Halma shares gained0.43% on 17 August 2026, extending investor interest in one of the UK's most consistent long-term growth companies.
Redx Pharma remains an important name within the UK biotechnology landscape because of its focus onfibrotic disease, an area with significant unmet medical needs.
GSK shares rose1.87% to approximately £18.52 on 17 August 2026, making the pharmaceutical company one of the stronger performers among major UK healthcare names during the session.
ConvaTec shares gained1.05% on 17 August 2026, placing LSE:CTEC among the stronger healthcare names in the market session.
ImmuPharma (LSE:IMM) has once again reminded shareholders how violently a micro-cap drug developer can move. The stock, which trades in low single-digit pence, gave back a chunk of its recent gains in a sharp one-day drop that a screener flagged at roughly 18%. That …
ProBiotix Health (LSE:PBX) has drifted lower in recent sessions, with a single-day screener snapshot pointing to a fall of roughly 8.3%. That kind of move looks dramatic in percentage terms, but it needs context: ProBiotix is a genuine micro-cap. The shares changed hands at …
Oxford Biomedica PLC — LSE:OXB gained1.75% on 17 August 2026, taking the shares to 495.50p.
Faron Pharmaceuticals has attracted renewed attention on17 August 2026, with LSE:FARN shares gaining5.91%.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…